An autopsy case of corticobasal degeneration with inferior olivary hypertrophy.
corticobasal degeneration
dentate nucleus
inferior olivary hypertrophy
olivary nucleus
tauopathies
Journal
Neuropathology : official journal of the Japanese Society of Neuropathology
ISSN: 1440-1789
Titre abrégé: Neuropathology
Pays: Australia
ID NLM: 9606526
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
revised:
09
12
2020
received:
10
08
2020
accepted:
18
12
2020
pubmed:
14
4
2021
medline:
26
11
2021
entrez:
13
4
2021
Statut:
ppublish
Résumé
We report autopsy results of a female patient who was confirmed pathologically as having corticobasal degeneration (CBD). This patient presented with progressive gait disturbance at the age of 66 years, and subsequently showed parkinsonism with a right-sided predominance and dementia. She was clinically diagnosed as having possible corticobasal syndrome without palatal myoclonus throughout the disease course. An autopsy at 72 years of age revealed that neuronal loss with gliosis was severe in the substantia nigra and the portion from hippocampal cornu ammonis (CA1) region to the parahippocampal gyrus, and mild-to-moderate in the basal ganglia, thalamus, red nucleus, dentate nucleus, and cerebral cortices, predominantly in the frontal lobe. Myelin pallor was observed in the pyramidal tract of the brainstem and central tegmental tract. Neurodegenerative or axonal degenerative findings were observed predominantly on the left side, except for the dentate nucleus, which was more affected on the right side. The inferior olivary nucleus exhibited hypertrophic degeneration predominantly on the left side. The topography of neurodegeneration was likely to correspond to the dentate nucleus and inferior olivary nucleus. Phosphorylated tau-immunoreactive pretangles, neurofibrillary tangles, coiled bodies, and threads were diffusely observed in the whole brain. The distribution of tau deposits was prominent in the deeper affected lesions of the dentate nucleus and inferior olivary nucleus. Inferior olivary hypertrophy is unusual in patients with CBD. It is highly possible that the neurodegeneration of the inferior olivary nucleus followed that of the dentate nucleus in our patient. Moreover, these results indicate not only the severity of neurodegenerative changes, but also that of tau deposition that could be related to the topography of the projections of the dentato-olivary pathway. Tau propagation and subsequent neurodegeneration along the fiber connections may have occurred. Our results support the possibility that progression of CBD lesions can be mediated by tau propagation.
Substances chimiques
tau Proteins
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
226-235Informations de copyright
© 2021 Japanese Society of Neuropathology.
Références
Horoupian DS, Wisniewski H. Neurofilamentous hyperplasia in inferior olivary hypertrophy. J Neuropathol Exp Neurol 1971; 30: 571-582.
Jellinger K. Hypertrophy of the inferior olives. Report on 29 cases. Z Neurol 1973; 205: 153-174.
Lapresle J, Hamida MB. The dentate-olivary pathway. Somatotopic relationship between the dentate neucleus and the contralateral inferior olive. Arch Neurol 1970; 22: 135-143.
Sabat S, Mannering N, Agarwal A. Hypertrophic olivary degeneration: Case series and review of literature. J Neurol Sci 2016; 370: 180-186.
Katsuse O, Dikson DW. Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy. Acta Neuropathol 2004; 108: 143-146.
Hanihara T, Amano N, Takahashi T, Itoh Y, Yagishita S. Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy. Eur Neurol 1998; 39: 97-102.
Giaccone G, Tagliavini F, Street JS, Ghetti B, Bugiani O. Progressive supranuclear palsy with hypertrophy of the olives. Acta Neuropathol 1988; 77: 14-20.
Takeuchi M, Sasaki S, Ito A, Osawa M, Kobayashi I, Maruyama S. An autopsy case of progressive supranuclear palsy with olivary hypertrophy. Brain Nerve 1991; 43: 863-867.(in Japanese with English abstract.).
Su M, Yoshida Y, Hirata Y, Satoh Y, Nagata K. Degeneration of the cerebellar dentate nucleus in corticobasal degeneration: Neuropathological and morphemetric investigations. Acta Neuropathol 2000; 99: 365-370.
Hideshima M, Beck G, Yamadera M et al. A clinicopathological study of ALS with L126S mutation in the SOD1 gene presenting with isolated inferior olivary hypertrophy. Neuropathology 2020; 40: 191-195.
Armstrong MJ, Litvan I, Lang AE et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 495-503.
Tokumaru AM, Saito Y, Murayama S et al. Imaging-pathologic correlation in corticobasal degeneration. Am J Neuroradiol 2009; 30: 1884-1892.
Taniguchi-Watanabe S, Arai T, Kametani F et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 2016; 131: 267-280.
Ikeuchi T, Imamura T, Kawase Y et al. Evidence for a common founder and clinical characteristics of Japanese families with the MAPT R406W mutation. Dement Geriatr Cogn Dis Extra 2011; 1: 267-275.
Dickson DW, Bergeron C, Chin SS et al. Office of rare disease neuropathologic criteria for corticobasaldegenerateon. J Neuropathol Exp Neurol 2002; 61: 935-946.
Mckee AC, Stein TD, Nowinski CJ et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 2013; 136: 43-64.
Armstrong RA, McKee AC, Stein TD, Alvarez VE, Cairns NJ. A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy. Neuropathol Appl Neurobiol 2017; 43: 154-166.
Fukushima K, Mizuno Y, Takatama M, Okamoto K. Increased neuronal expression of alpha B-crystallin in human olivary hypertrophy. Neuropathology 2006; 26: 196-200.
Ogawa K, Mizutani T, Uehara K, Minami M, Suzuki Y, Uchihara T. Pathological study of pseudohypertrophy of the inferior olivary nucleus. Neuropathology 2010; 30: 15-23.
Yoshii F, Tomiyasu H, Watanabe R, Rho M. MRI signal abnormalities of the inferior olivary nuclei in spinocerebellar ataxia type 2. Case Rep Neurol 2017; 9: 267-271.
Goto N, Kaneko M. Olivary enlargement: Chronological and morphometric analyses. Acta Neuropathol 1981; 54: 275-282.
Goyal M, Versnick E, Tuite P et al. Hypertrophic olivary degeneration: Metaanalysis of the temporal evolution of MR findings. Am J Neuroradiol 2000; 21: 1073-1077.
Haines DE. Neuroanatomy: An Atlas of Structures, Sections, and Systems, 4th edn. Baltimore, MD: Williams & Wilkins, 1995.
Mimuro M, Yoshida M. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration. Neuropathology 2020; 40: 57-67.
Voogd J, Ruigrok TJH. Cerebellum and precerebellar nuclei. In: Mai JK, Paxinos F, (eds). The Human Nervous System, 3th edn. London: Elsevier, 2012; 471-545.
Clavaguera F, Akatsu H, Fraser G et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A 2013; 110: 9535-9540.
Ahmed Z, Cooper J, Murray TK et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: The pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 2014; 127: 667-683.
Hasegawa M. Molecular mechanisms in the pathogenesis of Alzheimer's disease and tauopathies-prion-like seeded aggregation and phosphorylation. Biomolecules 2016; 6: 24.